Proposed Novel Mimicry States and Gut-Brain Proxies for Neuropsychological Health and Metabolic Resistance

Globally, metabolic and neuropsychological health challenges — such as diabetes, diabetic nephrotoxicity, obesity, fatty liver disease, metabolic syndrome, dementia, and depression — remain major issues, disproportionately affecting impoverished populations and those with high adverse childhood experience (ACE) scores. The gut microbiome plays a pivotal role in both metabolic regulation and mental health. Infant-like microbiota, characterized by high levels of Bifidobacteria and protective strains, promotes immune balance and anti-inflammatory resilience. Post-bariatric microbiota, observed after weight-loss surgery, enhances incretin release, bile acid signaling, and metabolic flexibility. This paper proposes a Hybrid Mimicry State (HMS), in which foundational states (GHNLMS, ILMS, or both) are combined with one or more adaptive profiles. The specific hypothesis advanced here is that the adaptive profile of post-bariatric patients’ microbiota, when combined with ILMS and/or GHNLMS, may provide synergistic metabolic benefits. Additionally, it is hypothesized that neuropsychological benefits are interconnected through HMS, GHNLMS, ILMS, sTDM, and GoldSyn proxies in conjunction or individually. Additional hypotheses supported by cited studies include reinforcement from supplementation, microbiota-rich foods, and botanicals through Synergistic Traditional Diet Mimicry (sTDM), which may also interact with adaptive profiles to strengthen outcomes. GoldSyn, a proposed practical proxy consortium of Bifidobacterium, Lactobacillus, and S. salivarius, could additionally serve as a vegan-available alternative. Together, these supports may improve gastrointestinal barrier integrity, systemic metabolic balance, and gut-brain signaling. Beyond improving glucose regulation and weight control, Hybrid Mimicry States are hypothesized to reduce complications of diabetes, including kidney failure, and may help slow the progression of Type 3c diabetes (Alzheimer’s and related dementias) via the gut-brain axis.